Contact UsHome

INVESTORS
News Releases
Events & Presentations
Board & Management Biographies
Corporate Governance
Financial Information
Stock Information
FAQs
Contact Us

 

 

News Releases

All Releases
View Summary OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Provides Outlook for 2010
Mar 8, 2010
PDF 22.6 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Webcast Discussion of Financial Results for Fourth Quarter and Fiscal Year 2009
Mar 4, 2010
PDF 12.1 KB Add to Briefcase
View Summary Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer
Mar 1, 2010
PDF 16.5 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at RBC Capital Markets' Healthcare Conference
Mar 1, 2010
PDF 11.9 KB Add to Briefcase
View Summary The European Medicines Agency is in Overall Agreement with OncoGenex Pharmaceuticals' Development Plan for OGX-011 in Patients with Metastatic Castrate-Resistant Prostate Cancer
Feb 25, 2010
PDF 15.9 KB Add to Briefcase
View Summary OncoGenex Announces Departure of Chief Financial Officer
Feb 25, 2010
PDF 13.6 KB Add to Briefcase
View Summary OncoGenex Announces that a Randomized, Investigator-Sponsored Phase 2 Study Evaluating OGX-427 has Received Grant Funding
Jan 6, 2010
PDF 16.7 KB Add to Briefcase
View Summary Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications
Dec 21, 2009
PDF 20.2 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Host Investor Conference Call at 8:30 a.m. ET, December 21, 2009
Dec 20, 2009
PDF 12.1 KB Add to Briefcase
View Summary OncoGenex Reports Third Quarter 2009 Financial Results
Nov 5, 2009
PDF 21.3 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
Nov 2, 2009
PDF 12.7 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals CEO Named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R) in the Health Sciences Category
Oct 9, 2009
PDF 14.1 KB Add to Briefcase
View Summary FDA Grants Additional Fast Track Designation for OGX-011 in Combination with First Line Chemotherapy
Oct 6, 2009
PDF 15.1 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
Sep 3, 2009
PDF 12.0 KB Add to Briefcase
View Summary OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
Aug 13, 2009
PDF 15.7 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
Aug 10, 2009
PDF 14.5 KB Add to Briefcase
View Summary OncoGenex Reports Second Quarter 2009 Financial Results
Aug 6, 2009
PDF 20.5 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
Aug 3, 2009
PDF 12.1 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
Jul 24, 2009
PDF 14.4 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
Jul 20, 2009
PDF 14.0 KB Add to Briefcase
Showing 1-20 of 214 Page: 1 2 3 ... 11  Next 20
= add release to Briefcase

 

 
  • Stock Information
Ticker: OGXI
Exchange: NASDAQ
Last Price: 18.68
Change: up 1.29
Volume: 165,900
3:59 PM ET - Mar 10, 2010



[ DISCLAIMER ] [ PRIVACY STATEMENT ]
© 2004-2010 Oncogenex Pharmaceuticals, Inc. All rights reserved.
Last Update: